GB:0GFH Stock Latest News
Company AnnouncementsIRLAB Wins Key U.S. Patent Boost for Next-Generation Parkinson’s Drug IRL11176d ago
Company AnnouncementsIRLAB names nomination committee ahead of 2027 AGM1w ago
Company AnnouncementsIRLAB Research on Potential First-in-Class Apathy Drug Linepemat Published1w ago
Company AnnouncementsIRLAB to Spotlight Parkinson’s Pipeline at Redeye Neurology Event3w ago
Company AnnouncementsIRLAB Therapeutics Names Janne Backman as Chairman to Steer Parkinson’s Pipeline and Partnerships1M ago
Company AnnouncementsIRLAB CEO to Step Down in 2027 as Parkinson’s Pipeline Advances2M ago
- Company AnnouncementsIRLAB to Webcast Q2 2026 Interim Report as Parkinson’s Pipeline Advances2M ago
Company AnnouncementsWHO Grants INN Name to IRLAB’s Apathy Drug Candidate Linepemat2M ago
Company AnnouncementsIRLAB Updates Share Capital After Rights Issue to Support Parkinson’s Pipeline3M ago
Company AnnouncementsIRLAB Completes Registration of Rights Issue and Converts Interim Shares3M ago
Company AnnouncementsIRLAB Therapeutics AGM Confirms No Dividend and New Director Incentives4M agoCompany AnnouncementsIRLAB Raises SEK 76.5 Million in Oversubscribed Rights and Overallotment Issues4M ago
Company AnnouncementsIRLAB’s Mesdopetam Shows Robust Phase II Efficacy in Integrated Analysis Ahead of Partnering Talks4M ago
- Company AnnouncementsIRLAB launches largely underwritten SEK 68 million rights issue4M ago
- Company AnnouncementsIRLAB Secures Strong Backing for SEK 68 Million Rights Issue5M ago
Company AnnouncementsIRLAB Shareholders Approve New Share Issues and Elect Two New Board Members5M ago
Company AnnouncementsIRLAB to Showcase Parkinson’s Pipeline at Stockholm Investor Event5M ago
Company AnnouncementsIRLAB boosts finances as LIFT-PD trial starts and milestone cash arrives6M agoCompany AnnouncementsIRLAB Calls Extraordinary Meeting to Approve Major Share Issues and Governance Changes6M ago
Company AnnouncementsIRLAB Launches Heavily Backed Rights Issue to Fund Pipeline and Extend Runway6M ago